Cubist Systematic Strategies’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Cubist Systematic Strategies’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-64,308	Closed	-$373K	–	4514
2023 Q1	$373K	Sell	64,308 -11,853	-16%	-$102K	﹤0.01%	2845
2022 Q4	$605K	Buy	76,161 +51,410	+208%	+$221K	﹤0.01%	2886
2022 Q3	$78K	Buy	+24,751	New	+$155K	﹤0.01%	4068
2022 Q2	–	Sell	-50,133	Closed	-$353K	–	4653
2022 Q1	$353K	Buy	+50,133	New	+$788K	﹤0.01%	2745

Other funds holding ICVX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

QUSVM

Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cubist Systematic Strategies's ICVX Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of Icosavax, Inc. Common Stock (ICVX) in Q2 2023, closing a stake of 64,308 shares — an estimated $373K sold.

Cubist Systematic Strategies first reported a position in ICVX in Q1 2022 and held it in 4 quarters. The position peaked at $605K in Q4 2022. 62 funds tracked by Wall St. Rank hold ICVX as of Q2 2023.

Cubist Systematic Strategies reported no remaining Icosavax, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 64,308 Icosavax, Inc. Common Stock shares in Q2 2023, an estimated $373K.
Cubist Systematic Strategies first reported a position in Icosavax, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Cubist Systematic Strategies's Icosavax, Inc. Common Stock position peaked at $605K in Q4 2022.
62 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.